USClinicalTrials.gov【Trial record】
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Phase 1RecruitingSource updated: Oct 1, 2026
Cancer types
Gastric Cancer
Stomach and gastroesophageal junction. 91 official records currently indexed across three regions.
Trial records retrieved live from the ClinicalTrials.gov public API.
Showing 91 of 91
Highlight terms:
Build a discussion list0 selected
Select the public official records you want to take to your appointment, then generate a list. Nothing is ranked or recommended — the list only reproduces titles and links.
Not signed in — up to 5 records per list. Sign in for higher free limits, or see Pro for more exports.
EUClinicalTrials.gov【Trial record】
HTL0039732 in Participants With Advanced Solid Tumours
Phase 1/2RecruitingSource updated: Oct 1, 2026
USClinicalTrials.gov【Trial record】
Imaging Study of [89Zr]DFO-YS5 for Cancer Detection
Phase 1RecruitingSource updated: Oct 1, 2026
USClinicalTrials.gov【Trial record】
Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
Phase 3Active, not recruitingSource updated: Oct 1, 2026
CNClinicalTrials.gov【Trial record】
Safety and Efficacy of NK510 to Treat Gastric Cancer and Colorectal Cancer
Early Phase 1RecruitingSource updated: Oct 1, 2026
USEUOTHERClinicalTrials.gov【Trial record】
Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
Phase 1Active, not recruitingSource updated: Oct 1, 2026
USOTHERClinicalTrials.gov【Trial record】
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Phase 2Active, not recruitingSource updated: Oct 1, 2026
CNClinicalTrials.gov【Trial record】
TEAS Timing for Gastrectomy Recovery (TEAS-TIME Trial)
Not applicableRecruitingSource updated: Oct 1, 2026
USOTHERClinicalTrials.gov【Trial record】
A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid Tumours
Phase 1Active, not recruitingSource updated: Sep 30, 2026
USClinicalTrials.gov【Trial record】
A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
Phase 1RecruitingSource updated: Sep 30, 2026
CNClinicalTrials.gov【Trial record】
A Prospective Real-World Observational Study of Intratumoral Oncolytic Virus Injection Combined With Immune Checkpoint Inhibitors for Metastatic Tumors (Colorectal Cancer, Gastric Cancer, and Hepatocellular Carcinoma)
RecruitingSource updated: Sep 30, 2026
OTHERClinicalTrials.gov【Trial record】
A Study to Investigate the Effects of AZD0901 Monotherapy in Adult Participants With 2L+ Advanced or Metastatic Gastric or GEJ Adenocarcinoma Expressing CLDN18.2
Phase 2Active, not recruitingSource updated: Sep 30, 2026
USEUCNOTHERClinicalTrials.gov【Trial record】
AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2
Phase 2RecruitingSource updated: Sep 30, 2026
USEUCNOTHERClinicalTrials.gov【Trial record】
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
Phase 1/2RecruitingSource updated: Sep 30, 2026
USClinicalTrials.gov【Trial record】
Improving Surgeon Performance Measures for Robot-Assisted Surgery
Enrolling by invitationSource updated: Sep 30, 2026
EUClinicalTrials.gov【Trial record】
Neoadjuvant Capecitabine, Oxaliplatin, Docetaxel and Atezolizumab in Resectable Gastric and GE-junction Cancer (PANDA)
Phase 2Active, not recruitingSource updated: Sep 30, 2026
CNClinicalTrials.gov【Trial record】
Silent Evaluation of DeepTRG for Assessing Tumor Response After Preoperative Treatment in Stomach and Gastroesophageal Junction Cancer
RecruitingSource updated: Sep 30, 2026
USClinicalTrials.gov【Trial record】
A Phase 1 Study of IM-1617 in Participants With Advanced Cancer
Phase 1RecruitingSource updated: Sep 29, 2026
USEUOTHERClinicalTrials.gov【Trial record】
A Safety and Efficacy Study of Treatment Combinations With and Without Chemotherapy in Adult Participants With Advanced Upper Gastrointestinal Tract Malignancies
Phase 2Active, not recruitingSource updated: Sep 29, 2026
USClinicalTrials.gov【Trial record】
A Trial to Evaluate Safety and Tolerability of TST001 in Advanced or Metastatic Solid Tumors
Phase 1/2Active, not recruitingSource updated: Sep 29, 2026
USEUOTHERClinicalTrials.gov【Trial record】
Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors
Phase 1RecruitingSource updated: Sep 29, 2026
OTHERClinicalTrials.gov【Trial record】
Combination of Osemitamab (TST001), Pembrolizumab and Chemotherapy as First-line Therapy in Advanced or Metastatic GC/GEJ Adenocarcinoma
Phase 3Not yet recruitingSource updated: Sep 29, 2026
USClinicalTrials.gov【Trial record】
DBC-664 in Adult Patients With Solid Tumors
Phase 1RecruitingSource updated: Sep 29, 2026
USClinicalTrials.gov【Trial record】
Non-covalent BTK Inhibitor Nemtabrutinib in Combination With the CD20 Monoclonal Antibody Rituximab for the Treatment of Marginal Zone Lymphoma
Phase 2RecruitingSource updated: Sep 29, 2026
USClinicalTrials.gov【Trial record】
Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
Phase 1/2RecruitingSource updated: Sep 29, 2026
USEUCNClinicalTrials.gov【Trial record】
Phase 3 Study of Cadonilimab Combined With Chemotherapy vs Chemotherapy in Combination With or Without Nivolumab for the 1L Treatment of Participants With HER2-negative, Previously Untreated, Unresectable or Metastatic Gastric/GEJ Adenocarcinoma
Phase 3RecruitingSource updated: Sep 29, 2026
USCNOTHERClinicalTrials.gov【Trial record】
Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers
Phase 1Active, not recruitingSource updated: Sep 29, 2026
USClinicalTrials.gov【Trial record】
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Phase 1RecruitingSource updated: Sep 28, 2026
USEUCNOTHERClinicalTrials.gov【Trial record】
A Study of Zolbetuximab (IMAB362) Plus CAPOX Compared With Placebo Plus CAPOX as First-line Treatment of Subjects With Claudin (CLDN) 18.2-positive, HER2-negative, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (GLOW).
Phase 3Active, not recruitingSource updated: Sep 28, 2026
USOTHERClinicalTrials.gov【Trial record】
IKS014 in Advanced Solid Tumors That Express HER2
Phase 1RecruitingSource updated: Sep 28, 2026
OTHERClinicalTrials.gov【Trial record】
Non-Invasive Artificial Intelligence-Based Platform MonIToring Program (NIP IT!)
RecruitingSource updated: Sep 28, 2026
USClinicalTrials.gov【Trial record】
Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or Targeted Therapy and/or ICI, for the Treatment of Patients With Advanced Gastrointestinal Cancers, Including Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)
Phase 1/2RecruitingSource updated: Sep 28, 2026
USEUCNOTHERClinicalTrials.gov【Trial record】
Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
Phase 2/3RecruitingSource updated: Sep 28, 2026
CNClinicalTrials.gov【Trial record】
The Application of 18F-G1 PET/CT Targeting Granzyme B in the Pan-cancer Immunotherapy
RecruitingSource updated: Sep 28, 2026
OTHERClinicalTrials.gov【Trial record】
Evaluation of XYA02 in Patients With Advanced Solid Tumors
Phase 1/2RecruitingSource updated: Sep 25, 2026
USEUCNOTHERClinicalTrials.gov【Trial record】
Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors
Phase 1/2RecruitingSource updated: Sep 25, 2026
CNClinicalTrials.gov【Trial record】
Home-based Whole Course Multimodal Prehabilitation Based on 5G + Artificial Intelligence Mobile Health
Not applicableNot yet recruitingSource updated: Aug 14, 2026
USClinicalTrials.gov【Trial record】
Magnetic Sentinel Lymph Node Mapping in Gastric Cancer
Phase 1Not yet recruitingSource updated: Aug 14, 2026
USClinicalTrials.gov【Trial record】
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
Phase 1RecruitingSource updated: Aug 13, 2026
USClinicalTrials.gov【Trial record】
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
Phase 2/3RecruitingSource updated: Aug 13, 2026
USClinicalTrials.gov【Trial record】
Surgery in Gastrointestinal Stromal Tumors (GISTs) for Treatment, Tumor Modeling, and Genomic Analysis
RecruitingSource updated: Aug 13, 2026
USClinicalTrials.gov【Trial record】
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
Phase 2/3RecruitingSource updated: Aug 12, 2026
USClinicalTrials.gov【Trial record】
ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With MAGE-A4 Positive Tumors (SURPASS)
Phase 1Active, not recruitingSource updated: Aug 12, 2026
OTHERClinicalTrials.gov【Trial record】
New bioMarkers tO straTIfy cOlorectal caNcer Referrals
RecruitingSource updated: Aug 12, 2026
USClinicalTrials.gov【Trial record】
Study of PRRT in Metastatic, WHO Grade 1 or 2, SSTR Positive, GEP-NET Who Are Candidates for Cytoreductive Surgery
Phase 1Active, not recruitingSource updated: Aug 12, 2026
USClinicalTrials.gov【Trial record】
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Phase 1/2RecruitingSource updated: Aug 11, 2026
USClinicalTrials.gov【Trial record】
Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
Phase 1RecruitingSource updated: Aug 11, 2026
EUClinicalTrials.gov【Trial record】
Cognitive Impact Associated With Surgery For Gastric Or Esophageal Cancer
RecruitingSource updated: Aug 11, 2026
OTHERClinicalTrials.gov【Trial record】
DURATION-GC: FLOT Plus Durvalumab and TS-1 Plus Durvalumab for Resectable Gastric Cancer
Phase 2Not yet recruitingSource updated: Aug 11, 2026
CNClinicalTrials.gov【Trial record】
Evaluation of Fecal Multi-target Biomarkers in the Screening of Digestive Tract Cancers
RecruitingSource updated: Aug 11, 2026
OTHERClinicalTrials.gov【Trial record】
Malignant Gastric Outlet Obstruction Study With Stomach Partitioning (GO-PART)
Not applicableRecruitingSource updated: Aug 11, 2026
USClinicalTrials.gov【Trial record】
Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations
Phase 2Active, not recruitingSource updated: Aug 11, 2026
CNClinicalTrials.gov【Trial record】
PD-1 Antibody Adjuvant Therapy for GC Patients With MSI-H After D2 Radical Surgery
Phase 2Active, not recruitingSource updated: Aug 11, 2026
CNClinicalTrials.gov【Trial record】
The Necessity of Surgery in Patients With mGC Achieving Radiological Response After Conversion Therapy
Phase 2RecruitingSource updated: Aug 11, 2026
CNClinicalTrials.gov【Trial record】
XNW27011 Study of Advanced Solid Tumor Subjects Who Failed Standard Therapies.
Phase 1/2Active, not recruitingSource updated: Aug 11, 2026
USClinicalTrials.gov【Trial record】
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Phase 2RecruitingSource updated: Aug 10, 2026
USClinicalTrials.gov【Trial record】
A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors
Phase 1RecruitingSource updated: Aug 10, 2026
USClinicalTrials.gov【Trial record】
KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting (SynerGIST-1st Line)
Phase 2RecruitingSource updated: Aug 10, 2026
OTHERClinicalTrials.gov【Trial record】
Preoperative Home-based Multimodal Prehabilitation Based on 5G + Artificial Intelligence Mobile Health
Not applicableNot yet recruitingSource updated: Aug 10, 2026
USClinicalTrials.gov【Trial record】
Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer
Phase 3RecruitingSource updated: Aug 10, 2026
USClinicalTrials.gov【Trial record】
Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer
RecruitingSource updated: Aug 7, 2026
EUClinicalTrials.gov【Trial record】
Organ Preservation With Durvalumab-based Immunotherapy in Combination With Chemoradiation as Definitive Therapy for Early Stage Esophageal Adenocarcinoma With Indication for Radical Surgery
Phase 2Active, not recruitingSource updated: Aug 7, 2026
USClinicalTrials.gov【Trial record】
Substudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06)
Phase 1/2RecruitingSource updated: Aug 7, 2026
OTHERClinicalTrials.gov【Trial record】
Surgical TreAtment for Obesity Related Disease and Onco-Metabolic Surgery
Not applicableRecruitingSource updated: Aug 7, 2026
USClinicalTrials.gov【Trial record】
Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
RecruitingSource updated: Aug 7, 2026
USClinicalTrials.gov【Trial record】
Validation of a Molecular Test for Risk-stratification of Patients With High-risk Intestinal Metaplasia (GCEP2 Study)
Active, not recruitingSource updated: Aug 7, 2026
USClinicalTrials.gov【Trial record】
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
Phase 1RecruitingSource updated: Aug 6, 2026
CNClinicalTrials.gov【Trial record】
Perioperative Oxaliplatin With S-1 Combined H. Pylori Eradication in the Management of Locally Advanced Gastric Cancer
Phase 2RecruitingSource updated: Aug 6, 2026
USClinicalTrials.gov【Trial record】
Total Neoadjuvant Therapy With Short Course Radiation Therapy in Gastric Cancer
Phase 2Not yet recruitingSource updated: Aug 6, 2026
CNCDE【Guideline / public regulatory information】
CDE 临床试验默示许可 — clinical trial implied licence notices
Index verified: Aug 16, 2026
CNCDE【Guideline / public regulatory information】
CDE 优先审评公示 — priority review listings
Index verified: Aug 16, 2026
CNCDE【Guideline / public regulatory information】
CDE 受理品种信息 — applications accepted for review
Index verified: Aug 16, 2026
CNCDE【Guideline / public regulatory information】
CDE 指导原则 — published technical guidance documents
Index verified: Aug 16, 2026
CNCDE【Guideline / public regulatory information】
CDE 突破性治疗公示 — breakthrough therapy designation notices
Index verified: Aug 16, 2026
CNCDE【Guideline / public regulatory information】
CDE 附条件批准品种 — conditionally approved products list
Index verified: Aug 16, 2026
CNChiCTR【Guideline / public regulatory information】
ChiCTR — Chinese Clinical Trial Registry, public search
Index verified: Aug 16, 2026
EUCTIS【Guideline / public regulatory information】
CTIS public register — search clinical trials authorised in the EU/EEA
Index verified: Aug 16, 2026
EUEMA【Guideline / public regulatory information】
EMA — CHMP meeting highlights and opinions on new medicines
Index verified: Aug 16, 2026
EUEMA【Guideline / public regulatory information】
EMA — medicines for human use currently under evaluation (monthly CHMP list)
Index verified: Aug 16, 2026
EUEMA【Guideline / public regulatory information】
EMA — searchable database of authorised medicines in the EU
Index verified: Aug 16, 2026
EUESMO【Guideline / public regulatory information】
ESMO Clinical Practice Guidelines — gastrointestinal cancers
Index verified: Aug 16, 2026
EUESMO【Guideline / public regulatory information】
ESMO Clinical Practice Guidelines — public index by tumour type
Index verified: Aug 16, 2026
EUESMO【Guideline / public regulatory information】
ESMO Clinical Practice Guidelines — supportive and palliative care section
Index verified: Aug 16, 2026
USFDA【Guideline / public regulatory information】
FDA — expanded access (compassionate use) information for patients
Index verified: Aug 16, 2026
USFDA【Guideline / public regulatory information】
FDA — oncology (cancer) / hematologic malignancies approval notifications
Index verified: Aug 16, 2026
USFDA【Guideline / public regulatory information】
FDA — ongoing accelerated approvals for oncology indications
Index verified: Aug 16, 2026
USNCCN【Guideline / public regulatory information】
NCCN Guidelines — palliative care category listing
Index verified: Aug 16, 2026
USNCCN【Guideline / public regulatory information】
NCCN Guidelines — public index by cancer type (free registration)
Index verified: Aug 16, 2026
USNCCN【Guideline / public regulatory information】
NCCN Guidelines for Patients — plain-language versions
Index verified: Aug 16, 2026
CNNMPA【Guideline / public regulatory information】
NMPA 药品 — national drug approval announcements
Index verified: Aug 16, 2026
CNCDE【Guideline / public regulatory information】
药物临床试验登记与信息公示平台 — national registry of drug trials conducted in China
Index verified: Aug 16, 2026